{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T19:20:46Z","timestamp":1781551246097,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jaci.2015.09.057","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T09:42:37Z","timestamp":1450777357000},"page":"710-717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Changing patterns of asthma medication use related to US Food and Drug Administration long-acting \u03b22-agonist regulation from 2005-2011"],"prefix":"10.1016","volume":"137","author":[{"given":"Melissa G.","family":"Butler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther H.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-te","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Chen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Levenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4947-3063","authenticated-orcid":false,"given":"Pingsheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sengwee","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarthi","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Iyasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan A.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"258","key":"10.1016\/j.jaci.2015.09.057_bib1","first-page":"1","article-title":"Summary health statistics for U.S. children: National Health Interview Survey, 2012. National Center for Health Statistics","author":"Bloom","year":"2013","journal-title":"Vital Health Stat 10"},{"issue":"260","key":"10.1016\/j.jaci.2015.09.057_bib2","first-page":"1","article-title":"Summary health statistics for U.S. adults: National Health Interview Survey, 2012. National Center for Health Statistics","author":"Blackwell","year":"2014","journal-title":"Vital Health Stat 10"},{"key":"10.1016\/j.jaci.2015.09.057_bib3","unstructured":"National Heart, Lung, and Blood Institute. Expert panel report 2: guidelines for the diagnosis and management of asthma. 1997. Available at: http:\/\/www.nhlbi.nih.gov\/guidelines\/archives\/epr-2\/asthgdln_archive.pdf. Accessed January 15, 2014."},{"key":"10.1016\/j.jaci.2015.09.057_bib4","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/bmj.306.6884.1034","article-title":"Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment","volume":"306","author":"Castle","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2015.09.057_bib5","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1001\/jama.285.20.2583","volume":"285","author":"Lazarus","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2015.09.057_bib6","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.285.20.2594","volume":"285","author":"Lemanske","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2015.09.057_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1378\/chest.124.1.70","article-title":"Serious asthma exacerbations in asthmatics treated with high-dose formoterol. Serious asthma exacerbations in asthmatics treated with high-dose formoterol","volume":"124","author":"Mann","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2015.09.057_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1378\/chest.129.1.15","article-title":"The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol","volume":"129","author":"Nelson","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2015.09.057_bib9","unstructured":"FDA. Information for healthcare professionals\u2014salmeterol xinafoate (marketed as Serevent Diskus). 2005. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm162673.htm. Accessed January 15, 2012."},{"key":"10.1016\/j.jaci.2015.09.057_bib10","unstructured":"National Heart, Lung, and Blood Institute. Expert panel report 3: guidelines for the diagnosis and management of asthma\u2014full report 2007. 2007. Available at: http:\/\/www.nhlbi.nih.gov\/guidelines\/asthma\/asthgdln.pdf. Accessed January 15, 2012."},{"key":"10.1016\/j.jaci.2015.09.057_bib11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.7326\/0003-4819-144-12-200606200-00126","article-title":"Meta-analysis: effect of long-acting beta agonists on severe asthma exacerbations and asthma-related deaths","volume":"144","author":"Salpeter","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2015.09.057_bib12","unstructured":"FDA. Advair Diskus, Advair HFA, Brovana, Foradil, Perforomist, Serevent Diskus, and Symbicort Information (Long Acting Beta Agonists). 2008. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm108111.htm. Accessed January 15, 2012."},{"key":"10.1016\/j.jaci.2015.09.057_bib13","unstructured":"FDA. FDA drug safety communication: new safety requirements for long-acting inhaled asthma medications called long-acting beta-agonists (LABAs). 2010. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm200776.htm. Accessed January 15, 2012."},{"key":"10.1016\/j.jaci.2015.09.057_bib14","doi-asserted-by":"crossref","first-page":"e1147","DOI":"10.1542\/peds.2010-1720","article-title":"Age and risks of FDA approved long-acting beta-adrenergic receptor agonists","volume":"128","author":"McMahon","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2015.09.057_bib15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJMp1014427","article-title":"Developing the Sentinel System\u2014a national resource for evidence development","volume":"364","author":"Behrman","year":"2011","journal-title":"N Engl J Med"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2015.09.057_bib16","first-page":"1","article-title":"The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction","volume":"21","author":"Platt","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2015.09.057_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/pds.2336","article-title":"Design considerations, architecture, and use of the Mini-Sentinel distributed data system","volume":"21","author":"Curtis","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaci.2015.09.057_bib18","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1016\/j.clinthera.2009.11.007","article-title":"Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma","volume":"31","author":"Blanchette","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaci.2015.09.057_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2466-10-29","article-title":"Prescribing patterns of asthma controller therapy for children in UK primary care: a cross-sectional observational study","volume":"10","author":"Thomas","year":"2010","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaci.2015.09.057_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jaci.2015.09.057_bib21","series-title":"Experimental and quasi-experimental designs for generalized causal inference","author":"Shadish","year":"2002"},{"key":"10.1016\/j.jaci.2015.09.057_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jclinepi.2008.08.007","article-title":"Methods for estimating confidence intervals in interrupted time series analyses of health interventions","volume":"62","author":"Zhang","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaci.2015.09.057_bib23","unstructured":"Bobbit LG, Otto MC. \u201cEffects of forecasts on the revisions of seasonally adjusted\u00a0data using the X-11 adjustment procedure,\u201d Proceedings of the Business and Economic Statistics Section of the American Statistical Association. 1990;449-53."},{"key":"10.1016\/j.jaci.2015.09.057_bib24","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jclinepi.2011.02.007","article-title":"Simulation-based power calculation for designing interrupted time series analyses of health policy interventions","volume":"64","author":"Zhang","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaci.2015.09.057_bib25","unstructured":"FDA. Early Communication about an Ongoing Safety Review of Montelukast (Singulair). 2008. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm070618.htm. Accessed May 30, 2014."},{"key":"10.1016\/j.jaci.2015.09.057_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1081-1206(10)60446-2","article-title":"Asthma-related medication use among children in the United States","volume":"100","author":"Korelitz","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2015.09.057_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/adc.2008.140681","article-title":"Prescribing trends in asthma: a longitudinal observational study","volume":"94","author":"Turner","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaci.2015.09.057_bib28","first-page":"e91","article-title":"Long-acting \u03b2-agonist monotherapy among children and adults with asthma","volume":"17","author":"Wasilevich","year":"2011","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaci.2015.09.057_bib29","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3109\/02770903.2013.803116","article-title":"An evaluation of asthma medication utilization for risk evaluation and mitigation strategies (REMS) in the United States: 2005-2011","volume":"50","author":"DiSantostefano","year":"2013","journal-title":"J Asthma"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674915016395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674915016395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:57:47Z","timestamp":1758790667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674915016395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0091674915016395"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2015.09.057","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing patterns of asthma medication use related to US Food and Drug Administration long-acting \u03b22-agonist regulation from 2005-2011","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2015.09.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}